|
March 2, 2004
Brian L. Strom, MD, MPH, Appointed Associate
Vice Dean and Associate Vice President for Strategic
Integration for PENN Medicine
(Philadelphia, PA) -- Brian L. Strom, MD, MPH,
has been appointed Associate Vice Dean of the University
of Pennsylvania School of Medicine and Associate
Vice President for Integrated Program Development for
the University of Pennsylvania Health System.
The appointments were announced jointly by Dr.
Arthur Rubenstein, Executive Vice President
of the University of Pennsylvania for the Health System
and Dean of the School of Medicine, and Health System
CEO Ralph Muller.
In his new position, Dr. Strom will be responsible for
the integration of the research, clinical and educational
activities of the medical school and health system.
“Dr. Strom’s primary charge in these positions
is to ensure that we take full advantage of our system-wide
resources in mission planning and operation,”
stated Dr. Rubenstein. “In conducting this effort
he will approach the review of existing activities and
the generation of new opportunities from an end-user
perspective that cuts across each of the major constituencies:
faculty, school and health system administration and
staff, and clinical and research trainees.”
Dr. Strom’s first specific project in this new
position is to develop an integrated vision for medical/biomedical
informatics at PENN Medicine (Penn’s
School of Medicine and the Health System). “Dr.
Strom will be reaching out to all components of this
area for participation, from patient registry and care
to health services and genomics research and education,”
explained Mr. Muller.
“I am excited to be taking on this new challenge,”
explained Dr. Strom. “Penn’s School of Medicine
is well recognized as one of the very best medical schools
in the country, and the Hospital of the University of
Pennsylvania is recognized as one of the nation’s
best hospitals.
"PENN Medicine is now one of the few truly integrated
academic health care systems. This creates tremendous
opportunities for further cross-fertilization, resulting
in enormous benefit for both the clinical and academic
parts of our operation. The results will be better for
our patients, for our students, and for the patients
of the future, who will benefit from our research.”
Dr. Strom is the George S. Pepper Professor of Public
Health and Preventive Medicine, Chair and Professor
of the Department of Biostatistics and Epidemiology,
Professor of Medicine, Professor of Pharmacology, Director
of the Center for Clinical Epidemiology and Biostatistics,
and Chair of the Graduate Group in Epidemiology and
Biostatistics at the School of Medicine. He will retain
these existing responsibilities, while fulfilling the
demands of his new positions.
On the Penn faculty since 1980, Dr. Strom’s research
interests span many areas of epidemiology; including
the field of pharmacoepidemiology, an area in which
he has authored over 350 manuscripts. He was a Yale
University undergraduate and earned his MD from the
Johns Hopkins University School of Medicine. He interned
and was a resident in Internal Medicine and a National
Institute of Health fellow in Clinical Pharmacology
at the University of California, Berkeley.
Dr. Strom’s academic talents and leadership skills
are also well recognized outside of Penn. He was a member
of the Board of Regents of the American College of Physicians,
the Board of Directors of the American Society for Clinical
Pharmacology and Therapeutics, and the Board of Directors
for the American College of Epidemiology. He serves
on the Drug Safety and Risk Management Advisory Committee
for the United States Food and Drug Administration (FDA).
He is an elected member of the Institute of Medicine
of the National Academy of Sciences. He chaired the
Institute Committee to Assess the Safety and Efficacy
of the Anthrax Vaccine, and is currently Chair of the
Institute Committee on Smallpox Vaccine Program Implementation.
Dr. Strom is one of only a handful of clinical epidemiologists
ever elected to the American Society of Clinical Investigation
and American Association of Physicians.
For
a printer friendly version of this release, click
here.
# # #
PENN Medicine is a $2.2
billion enterprise dedicated to the related missions
of medical education, biomedical research, and high-quality
patient care. PENN Medicine consists of the University
of Pennsylvania School of Medicine (founded in 1765
as the nation’s first medical school) and the
University of Pennsylvania Health System (created in
1993 as the nation’s first integrated academic
health system).
Penn’s School of Medicine is ranked #2 in
the nation for receipt of NIH research funds; and ranked
#4 in the nation in U.S. News & World Report’s
most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its
superior education and training of the next generation
of physician-scientists and leaders of academic medicine.
Penn Health System consists of four hospitals (including
its flagship Hospital of the University of Pennsylvania,
consistently rated one of the nation’s “Honor
Roll” hospitals by U.S. News & World Report),
a faculty practice plan, a primary-care provider network,
three multispecialty satellite facilities, and home
health care and hospice.
|
